Abstract
Human topoisomerase I (Top1) plays a pivotal role in cell replication and transcription, and therefore is an important anti-cancer target. Thiazolidinone and Azetidinone derivatives of 6-substituted 2-aminobenzothiazoles were synthesized and tested for their topoisomerase inhibitory activity and cytotoxicity by computational methods. Among the synthesized thiazolidinone and azetidinone analogs, compound 5avi and 6cvi exhibited potent topo I inhibitory activity and strong cytotoxicity. Interestingly, consistency was observed between the cytotoxicities and topo I activities in these thiazolidinone and azetidinone analogs, suggesting that the target of compound 5avi and 6cvi is limited to topo I. Molecular docking studies were performed with the Molecular Operating Environment (London DG Scoring Function) program to afford the ideal interaction mode of the compound into the binding site of the DNA–topo I complex in order to clarify the topo I activity of 5avi and 6cvi..
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
